X
20
Xellia Pharmaceuticals Ltd Budapest Hu, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Gramicidin, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2006-132 - Rev 06
This Chemical Type CEP, issued on December 18, 2018, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 907 associated with this CEP further emphasizes